Fig. 1
From: Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers
Intraindividual percentage ratios after treatment with empagliflozin or dapagliflozin in comparison to baseline values (Verum) and after placebo treatment in comparison to baseline values (Placebo) for plasma concentration of hArg, Arg, ADMA, SDMA, and creatinine. P-values calculated by two-sided paired t-tests; p-values refer to the percentage changes of biomarkers; adj. p-values computed based on the procedure of Benjamini and Hochberg